Operating Lease, Right-of-Use Asset of Inhibrx, Inc. from 31 Dec 2019 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Inhibrx, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2019 to 31 Mar 2024.
  • Inhibrx, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Mar 2024 was $2,487,000, a 42% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Inhibrx, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $2,487,000 -$1,803,000 -42% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $2,952,000 -$1,765,000 -37% 31 Dec 2023 10-Q 09 May 2024 2024 Q1
Q3 2023 $3,408,000 -$1,727,000 -34% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $3,853,000 -$1,692,000 -31% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 $4,290,000 -$1,656,000 -28% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 $4,717,000 -$1,621,000 -26% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 $5,135,000 -$1,588,000 -24% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $5,545,000 -$1,555,000 -22% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $5,946,000 -$1,523,000 -20% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $6,338,000 -$1,493,000 -19% 31 Dec 2021 10-K 06 Mar 2023 2022 FY
Q3 2021 $6,723,000 -$1,462,000 -18% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $7,100,000 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $7,469,000 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $7,831,000 +$378,000 +5.1% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 $8,185,000 30 Sep 2020 10-Q 13 Nov 2020 2020 Q3
Q4 2019 $7,453,000 31 Dec 2019 10-K 12 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.